甘油三酯-葡萄糖指数与脑小血管病及其影像学标志物关系研究

doi:10.3969/j.issn.1672-6731.2023.11.007

摘要/Abstract

摘要：

目的: 探讨甘油三酯-葡萄糖(TyG)指数与脑小血管病总负荷和脑小血管病影像学标志物的关系。方法: 纳入河北医科大学第三医院2020年1月至2022年5月确诊的202例脑小血管病患者，收集临床资料并计算TyG指数；MRI评估腔隙、脑微出血、脑白质高信号和扩大的血管周围间隙，计算脑小血管病总负荷评分。结果: (1) TyG指数与脑小血管病总负荷：Logistic回归分析显示，男性(OR=2.245，95%CI：1.017~4.957；P=0.045)、年龄增大(OR=1.084，95%CI：1.046~1.124；P=0.000)、高血压(OR=2.457，95%CI：1.189~5.078；P=0.015)和TyG指数升高(OR=2.657，95%CI：1.353~5.216；P=0.005)是中重度脑小血管病总负荷的危险因素。(2) TyG指数与脑小血管病影像学标志物：Logistic回归分析显示，TyG指数升高是中重度脑白质高信号(OR=2.313，95%CI：1.095~4.885；P=0.028)、脑微出血(OR=1.690，95%CI：1.011~2.824；P=0.045)、腔隙(OR=2.087，95%CI：1.235~3.525；P=0.006)和中重度基底节区扩大的血管周围间隙(OR=2.005，95%CI：1.190~3.378；P=0.009)的危险因素。结论: TyG指数与脑小血管病总负荷及其各项影像学标志物之间均存在关联性，可作为评估脑小血管病及其严重程度的生物学标志物。

关键词: 大脑小血管疾病, 甘油三酯类, 葡萄糖, 胰岛素抵抗, 危险因素, Logistic模型

Abstract:

Objective: To investigate the relationship between triglyceride glucose (TyG) index and the total load of cerebral small vessel disease (CSVD) and its different imaging markers. Methods: A total of 202 patients with CSVD admitted to The Third Hospital of Hebei Medical University from January 2020 to May 2022 were selected. The clinical data of all patients were collected and TyG index was calculated. The lacunes, cerebral microbleeds (CMBs), white matter hyperintensity (WMH) and enlarged perivascular space (EPVS) were evaluated by MRI, and total load of CSVD score was calculated. Results: 1) TyG index and total load of CSVD score: Logistic regression analysis showed the male (OR=2.245, 95%CI: 1.017-4.957; P=0.045), increase of age (OR=1.084, 95%CI: 1.046-1.124; P=0.000), hypertension (OR=2.457, 95%CI: 1.189-5.078; P=0.015) and increase of TyG index (OR=2.657, 95%CI: 1.353-5.216; P=0.005) were risk factors for moderate and severe total load of CSVD. 2) TyG index and imaging markers of CSVD: Logistic regression analysis showed the increase of TyG index was the risk factor of moderate and severe WMH (OR=2.313, 95%CI: 1.095-4.885; P=0.028), CMBs (OR=1.690, 95%CI: 1.011-2.824; P=0.045), lacunes (OR=2.087, 95%CI: 1.235-3.525; P=0.006), moderate and severe EPVS in basal ganglia (OR=2.005, 95%CI: 1.190-3.378; P=0.009). Conclusions: TyG index is associated with the total load and various imaging markers of CSVD, which can be used as a valuable biomarker to evaluate CSVD and its severity.

Key words: Cerebral small vessel disease, Triglycerides, Glucose, Insulin resistance, Risk factors, Logistic models

尹园园, 罗伟刚, 刘万虎, 步玮, 徐玉珠, 曹晓芸, 任慧玲. 甘油三酯-葡萄糖指数与脑小血管病及其影像学标志物关系研究[J]. 中国现代神经疾病杂志, 2023, 23(11): 993-1000.

Yuan-yuan YIN, Wei-gang LUO, Wan-hu LIU, Wei BU, Yu-zhu XU, Xiao-yun CAO, Hui-ling REN. Study on the relationship between triglyceride glucose index and cerebral small vessel disease and its different imaging markers[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2023, 23(11): 993-1000.

https://journal11.magtechjournal.com/cjcnn/CN/Y2023/V23/I11/993

图/表 15

参考文献 28

1	Writing Group of the "Chinese consensus on diagnosis and therapy of cerebral small vessel disease", Professional Committee of Cerebrovascular Diseases, Chinese Research Hospital Association. Chinese consensus on diagnosis and therapy of cerebral small vessel disease 2021. Zhongguo Zu Zhong Za Zhi, 2021, 16: 716- 726. doi: 10.3969/j.issn.1673-5765.2021.07.013
	中国研究型医院学会脑小血管病专业委员会《中国脑小血管病诊治专家共识》编写组. 中国脑小血管病诊治专家共识2021. 中国卒中杂志, 2021, 16: 716- 726. doi: 10.3969/j.issn.1673-5765.2021.07.013
2	Yang X, Zhang S, Dong Z, Zi Y, Luo Y, Jin Z, Shi L, Li C, Ren C, Wu D. Insulin resistance is a risk factor for overall cerebral small vessel disease burden in old nondiabetic healthy adult population. Front Aging Neurosci, 2019, 11: 127. doi: 10.3389/fnagi.2019.00127
3	Sánchez-García A, Rodríguez-Gutiérrez R, Mancillas-Adame L, González-Nava V, Díaz González-Colmenero A, Solis RC, Álvarez-Villalobos NA, González-González JG. Diagnostic accuracy of the triglyceride and glucose index for insulin resistance: a systematic review. Int J Endocrinol, 2020, ID4678526.
4	Jung DH, Park B, Lee YJ. Relationship of the triglyceride-glucose index with subclinical white matter hypersensitivities of presumed vascular origin among community-dwelling Koreans. Int J Gen Med, 2022, 15: 603- 608. doi: 10.2147/IJGM.S346997
5	Cai Y, Chen B, Zeng X, Xie M, Wei X, Cai J. The triglyceride glucose index is a risk factor for enlarged perivascular space. Front Neurol, 2022, 13: 782286. doi: 10.3389/fneur.2022.782286
6	Nam KW, Kwon HM, Lee YS. High triglyceride-glucose index is associated with early recurrent ischemic lesion in acute ischemic stroke. Sci Rep, 2021, 11: 15335. doi: 10.1038/s41598-021-94631-5
7	Zhang R, Zhou Y, Yan S, Zhong G, Liu C, Jiaerken Y, Song R, Yu X, Zhang M, Lou M. A brain region-based deep medullary veins visual score on susceptibility weighted imaging. Front Aging Neurosci, 2017, 9: 269. doi: 10.3389/fnagi.2017.00269
8	Staals J, Makin SD, Doubal FN, Dennis MS, Wardlaw JM. Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden. Neurology, 2014, 83: 1228- 1234. doi: 10.1212/WNL.0000000000000837
9	Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol, 1987, 149: 351- 356. doi: 10.2214/ajr.149.2.351
10	Kim JM, Park KY, Kim HR, Ahn HY, Pantoni L, Park MS, Han SH, Jung HB, Bae J. Association of bone mineral density to cerebral small vessel disease burden. Neurology, 2021, 96: e1290- e1300. doi: 10.1212/WNL.0000000000011526
11	Zhou M, Wang S, Jing J, Yang Y, Cai X, Meng X, Mei L, Lin J, Li S, Li H, Wei T, Wang Y, Pan Y, Wang Y. Insulin resistance based on postglucose load measure is associated with prevalence and burden of cerebral small vessel disease. BMJ Open Diabetes Res Care, 2022, 10: e002897. doi: 10.1136/bmjdrc-2022-002897
12	Unger G, Benozzi SF, Perruzza F, Pennacchiotti GL. Triglycerides and glucose index: a useful indicator of insulin resistance. Endocrinol Nutr, 2014, 61: 533- 540. doi: 10.1016/j.endonu.2014.06.009
13	da Silva A, Caldas APS, Hermsdorff HHM, Bersch-Ferreira ÂC, Torreglosa CR, Weber B, Bressan J. Triglyceride-glucose index is associated with symptomatic coronary artery disease in patients in secondary care. Cardiovasc Diabetol, 2019, 18: 89. doi: 10.1186/s12933-019-0893-2
14	Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord, 2008, 6: 299- 304. doi: 10.1089/met.2008.0034
15	Alizargar J, Bai CH. Comparison of carotid ultrasound indices and the triglyceride glucose index in hypertensive and normotensive community-dwelling individuals: a case control study for evaluating atherosclerosis. Medicina (Kaunas), 2018, 54: 71. doi: 10.3390/medicina54050071
16	Han T, Cheng Y, Tian S, Wang L, Liang X, Duan W, Na L, Sun C. Changes in triglycerides and high-density lipoprotein cholesterol may precede peripheral insulin resistance, with 2-h insulin partially mediating this unidirectional relationship: a prospective cohort study. Cardiovasc Diabetol, 2016, 15: 154. doi: 10.1186/s12933-016-0469-3
17	Irace C, Carallo C, Scavelli FB, De Franceschi MS, Esposito T, Tripolino C, Gnasso A. Markers of insulin resistance and carotid atherosclerosis: a comparison of the homeostasis model assessment and triglyceride glucose index. Int J Clin Pract, 2013, 67: 665- 672. doi: 10.1111/ijcp.12124
18	Nam KW, Kwon HM, Jeong HY, Park JH, Kwon H, Jeong SM. High triglyceride-glucose index is associated with subclinical cerebral small vessel disease in a healthy population: a cross-sectional study. Cardiovasc Diabetol, 2020, 19: 53. doi: 10.1186/s12933-020-01031-6
19	Wu D, Yang X, Zhong P, Ye X, Li C, Liu X. Insulin resistance is independently associated with enlarged perivascular space in the basal ganglia in nondiabetic healthy elderly population. Am J Alzheimers Dis Other Demen, 2020, 35: 1533317520912126.
20	Liu N, Xue Y, Tang J, Zhang MY, Ren X, Fu JH. Research progress of impaired cerebral hemodynamics in cerebral small vessel disease. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi, 2021, 21: 25- 29. doi: 10.3969/j.issn.1672-6731.2021.01.006
	刘娜, 薛扬, 唐杰, 张苗怡, 任雪, 付建辉. 脑小血管病血流动力学损害研究进展. 中国现代神经疾病杂志, 2021, 21: 25- 29. doi: 10.3969/j.issn.1672-6731.2021.01.006
21	Zhang HB, Guo YJ. Research progress of cerebral small vessel disease associated with immunoinflammatory mechanisms. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi, 2021, 21: 345- 349. doi: 10.3969/j.issn.1672-6731.2021.05.003
	张海波, 郭燕军. 脑小血管病相关免疫炎症机制研究进展. 中国现代神经疾病杂志, 2021, 21: 345- 349. doi: 10.3969/j.issn.1672-6731.2021.05.003
22	Muniyappa R, Chen H, Montagnani M, Sherman A, Quon MJ. Endothelial dysfunction due to selective insulin resistance in vascular endothelium: insights from mechanistic modeling. Am J Physiol Endocrinol Metab, 2020, 319: E629- E646. doi: 10.1152/ajpendo.00247.2020
23	Muniyappa R, Yavuz S. Metabolic actions of angiotensin Ⅱ and insulin: a microvascular endothelial balancing act. Mol Cell Endocrinol, 2013, 378: 59- 69. doi: 10.1016/j.mce.2012.05.017
24	Hoscheidt SM, Kellawan JM, Berman SE, Rivera-Rivera LA, Krause RA, Oh JM, Beeri MS, Rowley HA, Wieben O, Carlsson CM, Asthana S, Johnson SC, Schrage WG, Bendlin BB. Insulin resistance is associated with lower arterial blood flow and reduced cortical perfusion in cognitively asymptomatic middle-aged adults. J Cereb Blood Flow Metab, 2017, 37: 2249- 2261. doi: 10.1177/0271678X16663214
25	Ohishi M. Hypertension with diabetes mellitus: physiology and pathology. Hypertens Res, 2018, 41: 389- 393. doi: 10.1038/s41440-018-0034-4
26	Wang F, Han L, Hu D. Fasting insulin, insulin resistance and risk of hypertension in the general population: a meta-analysis. Clin Chim Acta, 2017, 464: 57- 63. doi: 10.1016/j.cca.2016.11.009
27	Soleimani M. Insulin resistance and hypertension: new insights. Kidney Int, 2015, 87: 497- 499. doi: 10.1038/ki.2014.392
28	Marfella R, Paolisso P, Sardu C, Palomba L, D'Onofrio N, Cesaro A, Barbieri M, Rizzo MR, Sasso FC, Scisciola L, Turriziani F, Galdiero M, Pignataro D, Minicucci F, Trotta MC, D'Amico M, Mauro C, Calabrò P, Balestrieri ML, Signioriello G, Barbato E, Galdiero M, Paolisso G. SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction. Crit Care, 2021, 25: 217. doi: 10.1186/s13054-021-03643-0

观察指标	轻度总负荷组(n = 91)	中重度总负荷组(n = 111)	统计量值	P值
性别[例(%)]			1.634	0.201
男性	51(56.04)	72(64.86)
女性	40(43.96)	39(35.14)
年龄($\bar x \pm s$，岁)	63.92 ± 10.56	69.98 ± 9.98	- 4.184	0.000
吸烟[例(%)]	26(28.57)	37(33.33)	0.528	0.467
饮酒[例(%)]	23(25.27)	33(29.73)	0.495	0.482
入院时收缩压($\bar x \pm s$，mm Hg)	148.84 ± 21.09	150.67 ± 20.32	- 0.627	0.532
入院时舒张压($\bar x \pm s$，mm Hg)	87.75 ± 13.64	86.19 ± 13.88	0.800	0.425
高血压[例(%)]	60(65.93)	91(81.98)	6.823	0.009
糖尿病[例(%)]	34(37.36)	50(45.05)	1.215	0.270
冠心病[例(%)]	19(20.88)	20(18.02)	0.263	0.608
高脂血症[例(%)]	28(30.77)	34(30.63)	0.000	0.983
空腹血糖[M(P₂₅，P₇₅)，mmol/L]	5.35 (4.80，6.30)	5.70 (5.00，7.00)	- 2.247	0.025
TC($\bar x \pm s$，mmol/L)	4.40 ± 0.96	4.37 ± 1.24	0.191	0.848
TG[M(P₂₅，P₇₅)，mmol/L]	1.03 (0.80，1.39)	1.15 (0.87，1.66)	- 1.779	0.075
LDL-C($\bar x \pm s$，mmol/L)	2.60 ± 0.72	2.51 ± 0.89	0.785	0.434
HDL-C[M(P₂₅，P₇₅)，mmol/L]	1.16 (0.97，1.35)	1.11 (0.93，1.33)	- 1.104	0.269
Hcy[M(P₂₅，P₇₅)，mmol/L]	13.75 (11.25，18.25)	14.90 (12.10，18.30)	- 1.384	0.166
TyG指数[M(P₂₅，P₇₅)]	8.42 (8.19，8.75)	8.62 (8.25，9.09)	- 2.388	0.017

观察指标	轻度总负荷组(n = 91)	中重度总负荷组(n = 111)	统计量值	P值
性别[例(%)]			1.634	0.201
男性	51(56.04)	72(64.86)
女性	40(43.96)	39(35.14)
年龄($\bar x \pm s$，岁)	63.92 ± 10.56	69.98 ± 9.98	- 4.184	0.000
吸烟[例(%)]	26(28.57)	37(33.33)	0.528	0.467
饮酒[例(%)]	23(25.27)	33(29.73)	0.495	0.482
入院时收缩压($\bar x \pm s$，mm Hg)	148.84 ± 21.09	150.67 ± 20.32	- 0.627	0.532
入院时舒张压($\bar x \pm s$，mm Hg)	87.75 ± 13.64	86.19 ± 13.88	0.800	0.425
高血压[例(%)]	60(65.93)	91(81.98)	6.823	0.009
糖尿病[例(%)]	34(37.36)	50(45.05)	1.215	0.270
冠心病[例(%)]	19(20.88)	20(18.02)	0.263	0.608
高脂血症[例(%)]	28(30.77)	34(30.63)	0.000	0.983
空腹血糖[M(P₂₅，P₇₅)，mmol/L]	5.35 (4.80，6.30)	5.70 (5.00，7.00)	- 2.247	0.025
TC($\bar x \pm s$，mmol/L)	4.40 ± 0.96	4.37 ± 1.24	0.191	0.848
TG[M(P₂₅，P₇₅)，mmol/L]	1.03 (0.80，1.39)	1.15 (0.87，1.66)	- 1.779	0.075
LDL-C($\bar x \pm s$，mmol/L)	2.60 ± 0.72	2.51 ± 0.89	0.785	0.434
HDL-C[M(P₂₅，P₇₅)，mmol/L]	1.16 (0.97，1.35)	1.11 (0.93，1.33)	- 1.104	0.269
Hcy[M(P₂₅，P₇₅)，mmol/L]	13.75 (11.25，18.25)	14.90 (12.10，18.30)	- 1.384	0.166
TyG指数[M(P₂₅，P₇₅)]	8.42 (8.19，8.75)	8.62 (8.25，9.09)	- 2.388	0.017

变量	赋值
变量	0	1
脑小血管病总负荷	轻度负荷	中重度负荷
性别	女性	男性
吸烟	无	有
饮酒	无	有
高血压	无	有
高脂血症	无	有
糖尿病	无	有
冠心病	无	有

变量	赋值
变量	0	1
脑小血管病总负荷	轻度负荷	中重度负荷
性别	女性	男性
吸烟	无	有
饮酒	无	有
高血压	无	有
高脂血症	无	有
糖尿病	无	有
冠心病	无	有

变量	b	SE	Wald χ²	P值	OR值	OR 95%CI
性别	- 0.370	0.290	1.628	0.202	0.691	0.391 ~ 1.219
年龄	0.058	0.015	15.123	0.000	1.059	1.029 ~ 1.090
吸烟	0.223	0.307	0.528	0.468	1.250	0.685 ~ 2.283
饮酒	0.224	0.318	0.494	0.482	1.251	0.670 ~ 2.334
高血压	0.855	0.332	6.647	0.010	2.351	1.227 ~ 4.502
糖尿病	0.318	0.289	1.212	0.271	1.374	0.780 ~ 2.420
冠心病	- 0.183	0.357	0.262	0.609	0.833	0.414 ~ 1.677
高脂血症	- 0.007	0.307	0.000	0.983	0.994	0.545 ~ 1.812
收缩压	0.004	0.007	0.395	0.530	1.004	0.991 ~ 1.018
舒张压	- 0.008	0.010	0.642	0.423	0.992	0.972 ~ 1.012
空腹血糖	0.153	0.086	3.151	0.076	1.166	0.984 ~ 1.381
TC	- 0.024	0.126	0.035	0.851	0.977	0.762 ~ 1.251
TG	0.504	0.229	4.835	0.028	1.655	1.056 ~ 2.592
LDL-C	- 0.136	0.177	0.594	0.441	0.873	0.617 ~ 1.234
HDL-C	- 0.458	0.494	0.860	0.354	0.633	0.240 ~ 1.665
Hcy	0.018	0.014	1.476	0.224	1.018	0.989 ~ 1.047
TyG指数	0.673	0.257	6.881	0.009	1.960	1.186 ~ 3.242

选择文件类型/文献管理软件名称

选择包含的内容

2 甘油三酯-葡萄糖指数与脑小血管病及其影像学标志物关系研究

Study on the relationship between triglyceride glucose index and cerebral small vessel disease and its different imaging markers

RichHTML

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

图/表 15

参考文献 28

相关文章 15

编辑推荐

Metrics

本文评价

观察指标	低TyG指数组(n = 133)	高TyG指数组(n = 69)	统计量值	P值
性别[例(%)]			4.548	0.033
男性	88(66.17)	35(50.72)
女性	45(33.83)	34(49.28)
年龄($\bar x \pm s$，岁)	66.86 ± 10.94	68.00 ± 10.10	- 0.718	0.474
吸烟[例(%)]	43(32.33)	20(28.99)	0.237	0.626
饮酒[例(%)]	41(30.83)	15(21.74)	1.837	0.171
入院时收缩压($\bar x \pm s$，mm Hg)	148.69 ± 20.84	152.06 ± 20.19	- 1.100	0.273
入院时舒张压($\bar x \pm s$，mm Hg)	87.41 ± 13.93	85.88 ± 13.46	0.749	0.455
空腹血糖[M(P₂₅，P₇₅)，mmol/L]	5.20 (4.70，5.90)	6.65 (5.60，8.48)	- 6.776	0.000
高血压[例(%)]	100(75.19)	51(73.91)	0.039	0.843
糖尿病[例(%)]	41(30.83)	43(62.32)	18.547	0.000
冠心病[例(%)]	21(15.80)	18(26.09)	3.092	0.079
高脂血症[例(%)]	23(17.29)	39(56.52)	32.865	0.000
WMH总评分[M(P₂₅，P₇₅)，评分]	3.00 (2.00，5.00)	4.00 (3.00，5.00)	- 3.161	0.002
存在腔隙[例(%)]	62(46.62)	44(63.77)	5.359	0.021
存在脑微出血灶[例(%)]	59(44.36)	38(55.07)	2.088	0.148
中重度EPVS[例(%)]	26(19.55)	24(34.78)	5.660	0.017
CSVD总负荷评分[M(P₂₅，P₇₅)，评分]	1.00 (0.00，3.00)	2.00 (1.00，3.00)	- 2.919	0.004
TC($\bar x \pm s$，mmol/L)	4.18 ± 1.02	4.76 ± 1.22	- 3.570	0.000
TG[M(P₂₅，P₇₅)，mmol/L]	0.94 (0.72，1.15)	1.83 (1.48，2.24)	- 10.172	0.000
LDL-C($\bar x \pm s$，mmol/L)	2.42 ± 0.78	2.83 ± 0.84	- 3.355	0.001
HDL-C[M(P₂₅，P₇₅)，mmol/L]	1.16 (0.97，1.37)	1.09 (0.91，1.21)	- 2.651	0.008
Hcy[M(P₂₅，P₇₅)，mmol/L]	14.60 (12.00，18.60)	14.00 (11.35，17.20)	- 0.799	0.425

[1]	倪洋, 张昉, 张勇, 林劲芝. 基于影像组学的神经血管压迫与原发性三叉神经痛关系探讨[J]. 中国现代神经疾病杂志, 2024, 24(8): 668-673.
[2]	谭波, 张钺, 杨佳强, 刘永东, 焦阳, 王贝. 创伤性脑疝患者去骨瓣减压术后脑积水危险因素分析以及贝叶斯网络模型构建[J]. 中国现代神经疾病杂志, 2024, 24(6): 442-449.
[3]	赵浩, 曲鑫, 王宁, 尚峰, 徐跃峤, 齐猛. 脑积水腰大池-腹腔分流术预后影响因素分析[J]. 中国现代神经疾病杂志, 2024, 24(6): 450-454.
[4]	米晓璐, 齐洪娜, 王维展, 孙少杰, 武艳品. 脂蛋白相关磷脂酶A2联合系统性炎症反应指数对急性一氧化碳中毒迟发性脑病的预测价值[J]. 中国现代神经疾病杂志, 2024, 24(6): 483-490.
[5]	叶睿曦, 蔡林君, 孔雪莹, 李劲梅, 周东, 洪桢. 抗N-甲基-D-天冬氨酸受体脑炎急性期严重程度及短期预后影响因素分析[J]. 中国现代神经疾病杂志, 2024, 24(5): 331-339.
[6]	徐坤榕, 王晓娟, 张弥兰, 薛红飞, 徐佳佳, 李玮. 单纯疱疹病毒1型脑炎临床特点及预后影响因素分析[J]. 中国现代神经疾病杂志, 2024, 24(4): 224-229.
[7]	熊冰婕, 曹飘, 张骏, 张海清. 隐球菌性脑膜炎预后不良危险因素分析及列线图预测模型构建[J]. 中国现代神经疾病杂志, 2024, 24(4): 230-237.
[8]	王建宇, 白云鹏. 主动脉夹层围手术期神经系统并发症的危险因素与治疗策略[J]. 中国现代神经疾病杂志, 2024, 24(2): 97-101.
[9]	王培健, 魏铭. 心脑血管疾病的预防与管理策略[J]. 中国现代神经疾病杂志, 2024, 24(2): 106-112.
[10]	贺中正, 李瑞乾, 刘志勇, 龙乾发, 岳树源, 杨彦平. 海拔4000米以上高原地区脑卒中临床特征：附103例分析[J]. 中国现代神经疾病杂志, 2023, 23(9): 859-863.
[11]	王亚伟, 田锋. 不同性别动脉粥样硬化差异性研究进展[J]. 中国现代神经疾病杂志, 2023, 23(9): 864-871.
[12]	冯珊珊. 基于危险因素的库欣病患者视力视野客观检查卫生经济学分析[J]. 中国现代神经疾病杂志, 2023, 23(7): 613-620.
[13]	潘希娟, 邢英琦, 刘玉梅. 脑小血管病影像学评分方法[J]. 中国现代神经疾病杂志, 2023, 23(7): 633-637.
[14]	邹婷婷, 马莉, 潘文静, 李长秀, 胡乃霞, 王擂. 重型颅脑创伤并发颅内感染危险因素分析及列线图预测模型构建[J]. 中国现代神经疾病杂志, 2023, 23(6): 496-502.
[15]	刘臣超, 刘慧权, 袁小勇, 王健, 陈绅, 王义义, 柳兴军. 重症结核性脑膜炎预后不良影响因素分析[J]. 中国现代神经疾病杂志, 2023, 23(6): 522-529.

变量	b	SE	Wald χ²	P值	OR值	OR 95%CI
性别	0.809	0.404	4.006	0.045	2.245	1.017 ~ 4.957
年龄	0.081	0.019	19.069	0.000	1.084	1.046 ~ 1.124
吸烟	0.370	0.410	0.814	0.367	1.448	0.648 ~ 3.236
高血压	0.899	0.370	5.889	0.015	2.457	1.189 ~ 5.078
高脂血症	- 0.001	0.405	0.000	0.998	0.999	0.452 ~ 2.210
糖尿病	- 0.307	0.368	0.696	0.404	0.736	0.358 ~ 1.513
Hcy	0.011	0.015	0.553	0.457	1.011	0.982 ~ 1.042
TyG指数	0.977	0.344	8.058	0.005	2.657	1.353 ~ 5.216
常数项	- 14.956	3.341	20.038	0.000

变量	b	SE	Wald χ²	P值	OR值	OR 95%CI
性别	0.809	0.404	4.006	0.045	2.245	1.017 ~ 4.957
年龄	0.081	0.019	19.069	0.000	1.084	1.046 ~ 1.124
吸烟	0.370	0.410	0.814	0.367	1.448	0.648 ~ 3.236
高血压	0.899	0.370	5.889	0.015	2.457	1.189 ~ 5.078
高脂血症	- 0.001	0.405	0.000	0.998	0.999	0.452 ~ 2.210
糖尿病	- 0.307	0.368	0.696	0.404	0.736	0.358 ~ 1.513
Hcy	0.011	0.015	0.553	0.457	1.011	0.982 ~ 1.042
TyG指数	0.977	0.344	8.058	0.005	2.657	1.353 ~ 5.216
常数项	- 14.956	3.341	20.038	0.000

变量	b	SE	Wald χ²	P值	OR值	OR 95%CI
年龄	0.075	0.018	18.137	0.000	1.077	1.041 ~ 1.115
高血压	0.491	0.360	1.860	0.173	1.635	0.807 ~ 3.312
高脂血症	0.547	0.383	2.037	0.154	1.727	0.815 ~ 3.659
糖尿病	0.622	0.350	3.155	0.076	1.862	0.938 ~ 3.697
Hcy	0.033	0.023	1.990	0.158	1.033	0.987 ~ 1.081
TyG指数	0.836	0.320	6.823	0.009	2.306	1.232 ~ 4.317

变量	b	SE	Wald χ²	P值	OR值	OR 95%CI
年龄	0.075	0.018	18.137	0.000	1.077	1.041 ~ 1.115
高血压	0.491	0.360	1.860	0.173	1.635	0.807 ~ 3.312
高脂血症	0.547	0.383	2.037	0.154	1.727	0.815 ~ 3.659
糖尿病	0.622	0.350	3.155	0.076	1.862	0.938 ~ 3.697
Hcy	0.033	0.023	1.990	0.158	1.033	0.987 ~ 1.081
TyG指数	0.836	0.320	6.823	0.009	2.306	1.232 ~ 4.317

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

2 甘油三酯-葡萄糖指数与脑小血管病及其影像学标志物关系研究

Study on the relationship between triglyceride glucose index and cerebral small vessel disease and its different imaging markers

RichHTML

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

图/表 15

参考文献 28

相关文章 15

编辑推荐

Metrics

本文评价